Actionable news
All posts from Actionable news
Actionable news in EXAS: EXACT Sciences Corporation,

Exact Sciences Could 'Take Off' if Key Product Rates Highly, Says Manager

NEW YORK (TheStreet) -- Exact Sciences (EXAS - Get Report) shares have pulled back in the past month due to a secondary offering and profit taking after a huge run-up. If the Preventive Services Task Force gives the company's Cologuard cancer screening product a high rating, however, the stock will take off, said Garvin Jabusch, chief investment officer for Green Alpha Advisors.

"It's already being used at the Mayo Clinic, they are obviously leaders in cancer prevention," said Jabusch. "They are also working on a non-invasive, just breathe into it, lung cancer screening so I do think there is reason to be cautious but the pullback could provide a really nice entry level should they get a favorable rating this year."

Shares of Exact Sciences have fallen 18% in the past...